                         SEQUENCE LISTING

<110>  Aldevron, LLC
       Paessler, Slobodan
       Veljkovic, Veljko
 
<120>  POTENT AND SELECTIVE INHIBITORS OF NAv1.7

<130>  18526.0002WOU1

<140>  PCT/US2021/051550
<141>  2021-09-22

<150>  US 63/082,088
<151>  2020-09-23

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 1

<400>  1

Ser Asp Glu Ile Pro Ala Thr Phe Gly Gly Gly Thr Asp Ala Gly Leu 
1               5                   10                  15      


<210>  2
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 3

<400>  2

Asp Cys Leu Gly Leu Phe Arg Lys Cys Ile Pro Asp Met Leu Lys Cys 
1               5                   10                  15      


Cys Arg Phe Asn Leu Val Cys Ser Arg Leu His Lys Trp Cys Lys Tyr 
            20                  25                  30          


Val Phe 
        


<210>  3
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 4

<400>  3

Asp Cys Leu Gly Leu Phe Arg Lys Cys Ile Pro Asp Asn Asp Lys Cys 
1               5                   10                  15      


Cys Arg Pro Asn Phe Val Cys Ser Arg Thr His Lys Val Cys Phe Tyr 
            20                  25                  30          


Val Leu 
        


<210>  4
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 5

<400>  4

Asp Cys Leu Gly Leu Phe Arg Lys Cys Ile Pro Asp Asn Asp Lys Cys 
1               5                   10                  15      


Cys Arg Pro Asn Leu Val Cys Ser Arg Thr His Lys Val Cys Phe Tyr 
            20                  25                  30          


Val Leu 
        


<210>  5
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 6

<400>  5

Asp Cys Leu Gly Met Phe Arg Lys Cys Leu Pro Asp Asp Asp Lys Cys 
1               5                   10                  15      


Cys Arg Pro Asn Leu Val Cys Ser Arg Thr His Lys Trp Cys Arg Leu 
            20                  25                  30          


Val Leu 
        


<210>  6
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 7

<400>  6

Ile Gly Glu Lys Val Thr Ile Arg Leu Ile Thr Ser Thr Asn Ile Asn 
1               5                   10                  15      


Asp Asp Phe Asn Ile Tyr Gln Gln Lys Pro Gly Glu Pro Pro Lys Leu 
            20                  25                  30          


Leu 
    


<210>  7
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 8

<400>  7

Asp Cys Leu Gly Phe Met Arg Lys Cys Leu Ser Thr Thr Asp Leu Asp 
1               5                   10                  15      


Asp Asp Trp Asn Cys Cys Arg Pro Asn Leu Val Cys Ser Arg Thr His 
            20                  25                  30          


Lys Trp Cys Lys Tyr Val Phe 
        35                  


<210>  8
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 10

<400>  8

Tyr Cys Gln Arg Phe Met Leu Thr Cys Asp Ser Lys Lys Ala Cys Cys 
1               5                   10                  15      


Glu Gly Leu Arg Cys Lys Leu Leu Cys Arg Lys Ile Ile 
            20                  25                  


<210>  9
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 11

<400>  9

Tyr Cys Gln Arg Trp Leu Trp Thr Cys Asp Ser Lys Lys Ala Cys Cys 
1               5                   10                  15      


Glu Gly Leu Arg Cys Lys Leu Trp Cys Arg Lys Ile Ile 
            20                  25                  


<210>  10
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide 12

<400>  10

Tyr Cys Leu Gly Phe Met Arg Lys Cys Asp Ser Glu Arg Lys Cys Cys 
1               5                   10                  15      


Glu Gly Met Val Cys Arg Leu Trp Cys Lys Arg Arg Leu Trp 
            20                  25                  30  


<210>  11
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synethtic Peptide 13

<400>  11

Ser Cys Arg Arg Ala Trp Met Ala Cys Asp Thr Ala Lys Val Cys Cys 
1               5                   10                  15      


Asn Pro Ile Lys Cys Arg Val Ala Cys Lys Arg Val Leu 
            20                  25                  


